The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., Jan. 29, 3:17 PM

Slide #2. Oxford Immunotec Global PLC Secondary Offering

Company: Oxford Immunotec Global PLC (NASDAQ:OXFD)
Date announced: 1/28/2015
Secondary Offering Details: Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, commercial-stage diagnostics company focused on developing and commercializing proprietary tests for the management of immune-regulated conditions, today announced that it has commenced an underwritten offering of its ordinary shares.

Oxford Immunotec Global is a commercial-stage diagnostics company. Co.'s proprietary T-SPOT® technology platform allows it to measure the responses of specific immune cells (T cells) to inform the diagnosis, prognosis and monitoring of patients with immunologically controlled diseases. Co.'s initial product is its T-SPOT.TB test is a single-cell based method for identifying latent Tuberculosis infection. Co. sells its T-SPOT.TB test in two formats: an in vitro diagnostic kit format, and a service format. Co. sells its T-SPOT.TB test through a direct sales force in the U.S., certain European countries and Japan. Co. sells through distributors in other parts of the world.
Open the OXFD Page at The Online Investor »

Company Name:  Oxford Immunotec Global Plc
Sector:  Biotechnology
Number of ETFs Holding OXFD:  11
Total Market Value Held by ETFs:  $4.52M
Total Market Capitalization:  $238.00M
% of Market Cap. Held by ETFs:  1.90%

Open the OXFD Page at The Online Investor (in a new window) »

January 29, 2015    3:17 PM Eastern
Quotes delayed 20 minutes

Strong Buy (4.00 out of 4)
96th percentile
(ranked higher than approx. 96% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | | Copyright © 1998 - 2015, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.